Articles in section Research & Development
<< Opinion & Analysis | 447 articles | Royalties >> |
<< Previous | Pages 1 ..7 8 9 10 11 12 .. 45 | Next >> |
-
GlaxoSmithKline Pays €45 M Upfront to Access Immatics’ Cell Therapy Platform
-
Servier Expands Cellectis UCART19 Collaboration
-
Ionis Signs Discovery Deals with Empirico and Aro
-
Sanofi Adds Depth to its Pipeline with US$2.6 B Nurix Collaboration
-
Astellas Partners with Adaptimmune on “Off-the-shelf” Cell Therapies
-
Incyte Pays US$900 M Upfront to Partner with MorphoSys for Tafasitamab
-
Merck Explores KRAS Inhibitors with US$2.55 B Taisho/Astex Deal
-
Takeda Buys into Viral Immunology with US$1 B Turnstone Deal
-
Neurocrine Signs US$1.7 B Epilepsy Pact with Xenon
-
Merck Signs Another Deal with 4D Pharma to Strengthen its Vaccine Portfolio